Doxecitine/doxribtimine, sold under the brand name Kygevvi, is a fixed-dose combination medication used for the treatment of thymidine kinase 2 deficiency. It contains the pyrimidine nucleosides, doxecitine (deoxycytidine) and doxribtimine (thymidine).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.